The glucose oxidase catalysed oxidation of glucose to gluconic acid and hydrogen peroxide forms the basis of several methods of measuring glucose concentration.' The most widely used approach for detection of the products is to use peroxidase in a colorimetric assay. The Yellow Springs (YS) glucose analyser (Yellow Springs Instruments, Yellow Springs, OH, USA) employs a peroxide sensitive electrode covered by a membrane containing immobilized glucose oxidase. The current produced is directly proportional to the glucose concentration.' The fact that the YS analyser requires only very small volumes of sample, is easy to use and gives results in under 45 seconds has made it popular in clinical and research settings. Surprisingly, there are few published comparisons of the YS with other methods of glucose measurement and all have relied on correlation and regression to assess agreement. Such techniques are inappropriate;' The aim of this study was to compare plasma glucose measurements on a YS glucose analyser (model 23AM) with measurements using an automated colorimetric glucose oxidase method on a Hitachi 717 analyser (Boehringer Mannheim UK, Lewes, UK).
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In a population-based prevalence study of glucose intolerance, 380 adults (197 women, 183 men, ages 25-64) had a World Health Organization (WHO) standard 75 g oral glucose tolerance test. Fasting and 2 h venous blood samples were collected in fluoride oxalate tubes centrifuged and the plasma was separated into two aliquots. One aliquot was analysed within 2 h using the YS analyser in the research laboratory where the glucose tolerance tests were performed and the other analysed the Correspondence: Dr N Unwin at the Department of Medicine. same day using the Hitachi 717 analyser in the department of clinical biochemistry. The YS analyser was operated by one of two research nursing sisters trained and with several years experience in its use. The machine was checked and calibrated daily following the maufacturer's instructions.? An aqueous standard solution (10 mmollL) obtained from the manufacturers was used to check and recalibrate the machine after every four measurements. The analyser was also checked daily using freeze-dried commercial serum standards prepared in the department of clinical biochemistry. The between batch coefficient of variation was 5· 1% at 1. 8 mmollL I ·70/0 at 5· 8 mmol/L at 2· 4% at 13· 0 mmollL: The Hitachi analyser was calibrated using commercial serum standards (Serum Calibrator Boehringer Mannheim UK, Lewes, UK). Thb etween batch coefficient of variation was 3·8070 at 2· 1 mmollL and 2· 4% at 14· 8 mmollL.
The main method used to assess agreement between the two methods of measurement is that recommended by Bland and Altman.'
Complete data were available on 755 pairs of measurements. The result from the Hitachi analyser was higher in 551 pairs, the same in 99 and lower in 105 (Wilcoxon matched pairs P<O·OOI). The mean difference for the fasting samples (Hitachi result minus YS) was 0·21 mmol/L (standard deviation 0·34 mrnol/L: 95% confidence interval O' 18-0'24 mmollL' P<O·OOI), and for the 2 h samples wa0 ·25 mmollL (standard deviation O·43 mrnol/L: 95% confidence interval O' 21-0'29 mmollL' P< 0,(01). On average the YS results were 3· 5OJ( 95% confidence interval 3 '1-3 '90/0) lower than the Hitachi results. Figure 1 and 11·5070 (43); and on the YS results they were 2·9% (11), and 9·6% (36), respectively. Thus, five individuals were classified as having diabetes using the Hitachi analyser but had IGT using the YS, and 12 individuals with IGT according to the Hitachi results were normal according to the YS results.
The data presented here show that, on average, results from the YS analyser are significantly lower than those from the automated colorimetric method on the Hitachi analyser. Previous comparisons of the results from a YS analyser and a manual glucose oxidase colorimetric method," a Kodak Ektachem analyser' and an Autoanalyser using the ferricyanide method' relied on correlation and regression to assess agreement. In all these comparisons whole blood glucose was measured on the YS. Results from the Ektachem (which used plasma) were corrected to whole blood values using a nomogram. The regression equations for these comprisons (YS results as dependent variable) were: Y = O:95X + 0·76 (manual glucose oxidase); Y = I .04X + 1·30 (Ektachem); and Y = 1.098X-0·9998 (ferricyanide). Thus, in these whole blood comparisons the YS tended to produce lower results than the ferricyanide method but not the other methods. Data from the National External Quality Assurance Scheme in the UK (which are based on standard serum samples) suggest that in general YS results are lower than those obtained using other glucose oxidase methods. The mean values from laboratories using Yellow Springs analysers between January 1991 and April 1994 were on average 4% lower than from laboratories using the glucose oxidase method either manually or with discrete analysers. Out of 61 pairs of means the YS mean was lower in 60 (data from UK National External Quality Assurance Scheme, Birmingham UK).
CONCLUSION
It appears that results from a YS analyser on plasma or serum samples are on average 3-4070 lower than results from other glucose oxidase methods. We do not know if these findings apply to the measurement of whole blood glucose. We speculate that one reason for the difference may be the use of an aqueous calibrant for the YS and a serum calibrant for other methods but the reasons for the difference require further investigation.
It would be wrong to conclude that our data indicate that the YS gives 'incorrect' results, because to reach this conclusion would require comparison to an agreed gold standard. Indeed, clinicallya difference of 4070 is of little importance, particularly given that each method has an overall coefficient of variation of up to 4%. However, it is important in a research setting. The YS and other glucose oxidase methods cannot be treated as directly comparable. In a given population the prevalence of diabetes and IGT based on YS measurements will be lower than those based on other glucose oxidase methods. The WHO criteria for the diagnosis of diabetes and impaired glucose tolerance were based on the results of studies using a mixture of methods (none used the YS). The recommended method of measurement of glucose in a WHO standard OGTT is 'a specific enzymic assay'. Our results suggest that this recommendation is too broad and should be re-examined.
